Laboratorio Farmaceutico SIT (“SIT”) announces the acquisition of the pharmaceutical product DERINOX from Therabel Lucien Pharma Sas, a reference medicine among topical decongestants. The product is indicated for the short-term symptomatic local treatment of congestive and inflammatory conditions during acute rhinitis, in adults and adolescents over 15 years of age. This acquisition will enable SIT to strengthen and expand its …
COUNTERFEITING: THE FIGHT AGAINST FAKES IS STARTING TO WORK
Roberto A. Jacchia interviewed by ItaliaOggi
[br]
DE BERTI JACCHIA WITH LABORATORIO FARMACEUTICO SIT IN THE ACQUISITION OF DINTOINA
With a team led by Partner Pietro Meda, the Firm assisted SIT in all phases of the transaction.
INTERNATIONAL CONFERENCE ON INFLUENCER MARKETING – Milan, 27 March 2025
[x_icon type="map-marker"] Milan[br]
[x_icon type="calendar"] 27 March 2025[br]
[x_icon type="user"] Andrea Terragni, Giulia Beneduci, Silvia Bolognani
AI DRAFT LAW: LAWYERS EXPLAIN THE NEW RULES
Jacopo Piemonte interviewed by Economy Magazine
[br]

